Amifostine (Ethyol®): Pharmacokinetic and Pharmacodynamic Effects in vivo
- 31 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32, S26-S30
- https://doi.org/10.1016/s0959-8049(96)00332-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 962 Bone marrow protection by amifostine (AMI) in patients treated with carboplatin (CARBO): A phase I studyEuropean Journal Of Cancer, 1995
- Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated miceEuropean Journal Of Cancer, 1994
- Phase I study of WR-2721 and carboplatinEuropean Journal Of Cancer, 1993
- Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceEuropean Journal Of Cancer, 1992
- Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamateBiochemical Pharmacology, 1992
- Clinical Pharmacokinetics of CarboplatinClinical Pharmacokinetics, 1991
- Pharmacokinetics of WR-2721Pharmacology & Therapeutics, 1988
- Can WR-2721 be improved upon?Pharmacology & Therapeutics, 1988
- The mechanism of action of platinum antitumor drugsPure and Applied Chemistry, 1987
- Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and TissuesJournal of Liquid Chromatography, 1986